ArticleInflammatory bowel diseases2018

Gene Signature-Based Approach Identified MEK1/2 as a Potential Target Associated With Relapse After Anti-TNFα Treatment for Crohn's Disease.

Kanae Gamo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.